The Drug-Induced Respiratory Disease Website

Anticoagulants, oral (vitamin K antagonists-VKA)

Epistaxis

Review at PMID 30454778. Emergent management at PMID 27836741

Escabasse V, Bequignon E, Vérillaud B, Robard L, Michel J, Malard O, Crampette L,

Guidelines of the French Society of Otorhinolaryngology (SFORL). Managing epistaxis under coagulation disorder due to antithrombotic therapy.

European annals of otorhinolaryngology, head and neck diseases 2017 May;134;195-199 — 2017 May — 195-199

Diagnosing DIRD

Drug and radiation history

Drug singularity - Correct identification of the drug

Consistent timing of exposure v. onset of symptoms

Clinical, imaging, BAL, pathological pattern consistent with the specific drug

Careful exlusion of another cause

Remission of symptoms with removal of drug

Recurrence with rechallenge (rarely advisable)

Causality assessment

LATEST CHANGELOG

No activity has been recorded yet.